A Non Profit Organization
EPEMED Luxembourg asbl is a non-profit organization under the Luxembourg law, registered in Luxembourg at 59, rue du dix Octobre, L-7243 Luxembourg Bereldange.
The organisation is directed by an Executive Director comprised of a dynamic and diverse group of European leaders in the personalised medicine field, who have great expertise in the application and development of diagnostic tools to deliver improved patient care.
Werner Verbiest joined Johnson & Johnson in 1991 as an employee of the International Clinical R&D group of the Janssen Research Foundation. In this role, he was active in HIV drug development and Hepatitis B therapeutic vaccine development.
In 1998, Werner joined Virco as Project Director, Business Development. Virco’s primary focus was laboratory testing for viral resistance to HIV drugs used to treat patients with HIV/AIDS. As one of the first employees at Virco, Werner has been involved in the growth and development of the company since its inception. He has been active in all phases of HIV clinical trial implementation and resistance-test development, and has contributed to numerous papers and presentations on antiretroviral resistance.
Werner was promoted to Managing Director, Virco Ireland Ltd. in 2002 and was given the additional responsibilities of Vice President, New Products Marketing and Pharma Business in the same year.
Next to leading Virco, Werner became Global Head of the Companion Diagnostics Center of Excellence and Veridex. Veridex is a Johnson and Johnson/Janssen company dedicated to providing physicians with high-value in vitro diagnostic oncology products through earlier disease detection and personalized diagnostic tools to improve patient management and outcomes.
All three groups—Virco, Veridex, and the Companion Diagnostics Center of Excellence—were united under one umbrella in October 2011 as Janssen Diagnostics, of which Werner is the Global Head. In this capacity, Werner plays a leading role in advocating for and actualizing a personalized medicine approach within Johnson & Johnson/Janssen.
Werner earned a combined Masters in Biology and Biotechnology from the University of Antwerp (Belgium, EU) and a post-graduate degree in Business Management / MBA from the University of Utrecht (The Netherlands, EU).